| # | Drug | Count |
|---|---|---|
| 0 | LEVOTHYROXINE SODIUM | 100 |
| 1 | ALPRAZOLAM | 80 |
| 2 | ATORVASTATIN CALCIUM | 77 |
| 3 | QUETIAPINE | 71 |
| 4 | QUETIAPINE FUMARATE | 57 |
| 5 | SOMATROPIN | 56 |
| 6 | DULOXETINE | 38 |
| 7 | DULOXETINE HYDROCHLORIDE | 38 |
| 8 | LANREOTIDE ACETATE | 30 |
| 9 | HYDROCORTISONE | 27 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HYPROMELLOSE 2208 (15000 MPA.S) | 1 | 0.0233 |
| 1 | ALFUZOSIN HYDROCHLORIDE | 26 | 0.0105 |
| 2 | LANREOTIDE ACETATE | 30 | 0.0038 |
| 3 | CORTISOL | 1 | 0.0025 |
| 4 | THIOTEPA | 15 | 0.0015 |
| 5 | GATIFLOXACIN | 2 | 0.0011 |
| 6 | BUSULFAN | 13 | 0.0008 |
| 7 | SOMATROPIN | 56 | 0.0007 |
| 8 | PRASTERONE | 2 | 0.0007 |
| 9 | RIFABUTIN | 2 | 0.0007 |
| # | Drug class | Count |
|---|---|---|
| 0 | Benzodiazepine [EPC] | 99 |
| 1 | Corticosteroid [EPC] | 59 |
| 2 | Alkylating Drug [EPC] | 45 |
| 3 | Recombinant Human Growth Hormone [EPC] | 33 |
| 4 | HMG-CoA Reductase Inhibitor [EPC] | 28 |
| 5 | Platinum-based Drug [EPC] | 25 |
| 6 | Topoisomerase Inhibitor [EPC] | 23 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 19 |
| 8 | Provitamin D2 Compound [EPC] | 18 |
| 9 | Atypical Antipsychotic [EPC] | 17 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Recombinant Human Growth Hormone [EPC] | 33 | 0.0015 |
| 1 | Provitamin D2 Compound [EPC] | 18 | 0.0006 |
| 2 | Rifamycin Antimycobacterial [EPC] | 2 | 0.0006 |
| 3 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 4 | 0.0004 |
| 4 | Topoisomerase Inhibitor [EPC] | 23 | 0.0003 |
| 5 | Somatostatin Analog [EPC] | 2 | 0.0003 |
| 6 | Serotonin and Norepinephrine Reuptake Inhibitor [EPC] | 1 | 0.0003 |
| 7 | Iron Chelator [EPC] | 7 | 0.0002 |
| 8 | Quinolone Antimicrobial [EPC] | 2 | 0.0002 |
| 9 | Alkylating Drug [EPC] | 45 | 0.0002 |